Menglin Xiao

894 total citations
29 papers, 598 citations indexed

About

Menglin Xiao is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Menglin Xiao has authored 29 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Biomaterials. Recurrent topics in Menglin Xiao's work include Silk-based biomaterials and applications (6 papers), Cancer-related molecular mechanisms research (6 papers) and Glioma Diagnosis and Treatment (5 papers). Menglin Xiao is often cited by papers focused on Silk-based biomaterials and applications (6 papers), Cancer-related molecular mechanisms research (6 papers) and Glioma Diagnosis and Treatment (5 papers). Menglin Xiao collaborates with scholars based in China, United States and Japan. Menglin Xiao's co-authors include Yanli Tan, Chuan Fang, Biao Hong, Chunsheng Kang, Jixing Zhao, Qixue Wang, Can Xu, Xiaoteng Cui, Yuhao Zhang and Fulin Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cleaner Production and Scientific Reports.

In The Last Decade

Menglin Xiao

27 papers receiving 592 citations

Peers

Menglin Xiao
Haiwen Ma China
Lihua Xu China
Rui Dong China
Haiying Pan United States
Menglin Xiao
Citations per year, relative to Menglin Xiao Menglin Xiao (= 1×) peers Jingjing Zheng

Countries citing papers authored by Menglin Xiao

Since Specialization
Citations

This map shows the geographic impact of Menglin Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menglin Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menglin Xiao more than expected).

Fields of papers citing papers by Menglin Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Menglin Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menglin Xiao. The network helps show where Menglin Xiao may publish in the future.

Co-authorship network of co-authors of Menglin Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Menglin Xiao. A scholar is included among the top collaborators of Menglin Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Menglin Xiao. Menglin Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Menglin, Hao Fu, Jinrong Yao, et al.. (2025). Controllable fabrication of silk fibroin porous scaffolds and their regulation on cellular behaviours. Journal of Materials Chemistry B. 13(18). 5453–5465.
2.
Xiao, Menglin, Ling Chen, Bingjiao Zhao, et al.. (2025). Hemostatic, Antimicrobial, and Thixotropic Hydrogels Based on Natural Silk Nanofibril/Halloysite Nanotube/Extracellular Vesicle Hybrids. Advanced Materials Technologies. 10(13).
3.
Xiao, Menglin, Liangyan Sun, Kang Wu, et al.. (2025). A sequential drug delivery system based on silk fibroin scaffold for effective cartilage repair. Bioactive Materials. 49. 255–270. 3 indexed citations
4.
Chen, Ling, Menglin Xiao, Liangyan Sun, et al.. (2024). Super Stable Silk Nanofibrils Prepared by an Improved Exfoliation Method and Their Related Applications. Advanced Materials Technologies. 9(20). 3 indexed citations
5.
Sun, Liangyan, Menglin Xiao, Ling Chen, et al.. (2024). Enhanced Tissue Regeneration Through Immunomodulatory Extracellular Vesicles Encapsulated in Diversified Silk‐Based Injectable Hydrogels. Advanced Healthcare Materials. 13(28). e2401460–e2401460. 15 indexed citations
6.
Xu, Can, Xiang Li, Menglin Xiao, et al.. (2024). Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition. Cancer Biology and Medicine. 21(5). 1–19. 14 indexed citations
7.
Xiao, Menglin, et al.. (2024). Revealing the mechanism of flavor improvement of fermented goat milk based on lipid changes. Food Chemistry. 458. 140235–140235. 12 indexed citations
8.
Xiao, Menglin, Xiaoteng Cui, Jixing Zhao, et al.. (2024). Deep‐targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma. CNS Neuroscience & Therapeutics. 30(4). e14698–e14698. 6 indexed citations
9.
Cui, Xiaoteng, Jixing Zhao, Guanzhang Li, et al.. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Communications. 43(12). 1326–1353. 22 indexed citations
10.
Lei, Xin, Yanli Tan, Xiaoteng Cui, et al.. (2023). EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT. Neuro-Oncology. 25(11). 1976–1988. 12 indexed citations
11.
Peng-fei, Zhang, Zhaorui Zhang, Menglin Xiao, et al.. (2023). Effects of organic mulching on moisture and temperature of soil in greenhouse production of tomato under unheated greenhouse cultivation in the cold zone of China. Food Science & Nutrition. 11(8). 4829–4842. 8 indexed citations
12.
Xiao, Menglin, et al.. (2023). Regenerated silk fibroin based on small aperture scaffolds and marginal sealing hydrogel for osteochondral defect repair. Biomaterials Research. 27(1). 50–50. 20 indexed citations
13.
Zhang, Pengfei, Menglin Xiao, Zhaorui Zhang, et al.. (2023). Hydrological characteristics of different organic materials mulches. Scientific Reports. 13(1). 771–771. 3 indexed citations
14.
Xu, Can, Jixing Zhao, Jia L. Song, et al.. (2022). lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy. Frontiers in Oncology. 12. 888922–888922. 13 indexed citations
15.
Yang, Eryan, Lin Wang, Weili Jin, et al.. (2022). PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma. Theranostics. 12(9). 4330–4347. 27 indexed citations
16.
Yang, Shixue, Jixing Zhao, Xiaoteng Cui, et al.. (2022). TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma. Theranostics. 12(16). 7032–7050. 36 indexed citations
17.
Xu, Can, Menglin Xiao, Xiang Li, et al.. (2022). Origin, activation, and targeted therapy of glioma-associated macrophages. Frontiers in Immunology. 13. 974996–974996. 43 indexed citations
18.
Yi, Kaikai, Xiaoteng Cui, Xing Liu, et al.. (2022). PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma. Frontiers in Immunology. 12. 802795–802795. 26 indexed citations
19.
Zhang, Yuhao, Xiuchao Geng, Qiang Li, et al.. (2021). Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma. Journal of Cellular and Molecular Medicine. 25(15). 7204–7217. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026